Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
Global Oral Antibiotics Market: By Class: Beta Lactam and Beta Lactamase Inhibitors, Quinolones, Macrolides, Others; By Application; By Drug Origin; By Spectrum of Activity; By Drug Type; Regional Analysis; Historical Market and Forecast (2018-2028); Market Dynamics: SWOT Analysis; Competitive Landscape; Industry Events and Developments
Global Oral Antibiotics Market Outlook
The global oral antibiotics market attained a value of over USD 18,365.8 million in 2021. The market is further expected to grow in the forecast period of 2023-2028 at a CAGR of 2.7% to reach more than USD 23,306.1 million by 2027.
Extensive Use of Oral Antibiotics to Treat Infectious Diseases Driving the Market Growth
The extensive use of oral antibiotics for the treatment of infectious diseases, such as influenza and tuberculosis, among others, is aiding the market growth. As oral antibiotics are extensively prescribed for mild issues such as cough, their demand is significantly surging. The increasing cost-effectiveness of oral antibiotics in both developed and developing countries is also fuelling the market growth.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Furthermore, the increasing approvals of oral antibiotics by government bodies to enhance treatment options for infectious diseases is augmenting the market growth. For instance, in August 2019, the Food and Drug Administration (FDA) of the United States approved Xenleta (lefamulin) for the treatment of community-acquired bacterial pneumonia.
The growing prevalence of urinary tract infections (UTIs), especially in women, is significantly surging the demand for oral antibiotics such as Fosfomycin and ceftriaxone, among others. Oral antibiotics such as analgesic to relieve pain are also prescribed for the treatment of such infections, which is bolstering the market growth. As the accessibility to healthcare in low-income countries is increasing due to various government initiatives, patients are increasingly seeking treatment of urinary tract infections (UTIs), hence driving the market for oral antibiotics. Moreover, the development of multidrug oral antibiotics for the effective treatment of urinary tract infections (UTIs) is anticipated to provide further impetus to the growth of the market in the forecast period.
Oral Antibiotics: Market Segmentation
Oral antibiotics refer to medical drugs such as tablets and capsules that are administered orally and are used to treat mild to moderate infections in the body. They eliminate the risk of canula-related infections to enhance the cost-effectiveness while effectively treating infectious diseases. Moreover, oral antibiotics are typically used to kill microbes in the body.
The major classes of oral antibiotics are:
- Beta Lactam and Beta Lactamase Inhibitors
- Quinolones
- Macrolides
- Others
The beta lactam and beta lactamase inhibitors segment is further divided into penicillin and cephalosporin, among others.
The market can be broadly categorised on the basis of its applications into:
- Community-Acquired Respiratory Tract Infections (CARTIs)
- Urinary Tract Infections (UTIs)
- Dental
- Others
The community-acquired respiratory tract infections (CARTIs) segment is bifurcated into upper respiratory tract infections (URTI) and lower respiratory tract infections (LRTIs). Meanwhile, the dental segment is classified into combination and monotherapies.
Based on drug origin, the market is divided into:
- Natural
- Semisynthetic
- Synthetic
By spectrum of activity, the market is bifurcated into:
- Broad-spectrum Antibiotic
- Mid/Narrow-spectrum Antibiotic
The market, based on drug type, is classified into:
- Branded
- Generics
The EMR report looks into the regional markets of oral antibiotics like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Increasing Research Activities to Develop New Oral Antibiotics to Propel the Market Growth
The growing focus on global health threats, in the wake of the COVID-19 pandemic, is increasing the requirement for the development of new oral antibiotics, which is anticipated to drive the industry growth. As the development of new oral antibiotics is extremely complex, various antibacterial research activities are initiated to understand the structure of bacteria, which is estimated to propel the market growth. Leading companies are increasingly partnering with private and public bodies to accelerate research and development (R&D) activities to address barriers in discovering novel oral antibiotics. This, in turn, is estimated to contribute significantly to the market for oral antibiotics in upcoming years.
The increasing investment in the development of innovative oral antibiotics is projected to augment the industry growth. The introduction of various regulatory standards by healthcare bodies to effectively standardise guidelines for clinical trials of oral antibiotics is projected to augment the market growth. With the rising interest in transforming the goals of antibiotics therapy to neutralise the microbes and boost resistance to diseases, the use of oral antibiotics for the treatment of serious infections is anticipated to increase, which is predicted to aid the market growth in the forecast period.
Key Industry Players in the Global Oral Antibiotics Market
The report presents a detailed analysis of the following key players in the global oral antibiotics market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Glaxosmithkline plc
- Abbott Laboratories
- Allergan Plc
- Hoffmann-La Roche Ltd.
- Pfizer Inc.
- Others
The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2018-2022 |
| Forecast Period | 2023-2028 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Class, Application, Drug Origin, Spectrum of Activity, Drug Type, Region |
| Breakup by Class | Beta Lactam and Beta Lactamase Inhibitors, Quinolones, Macrolides, Others |
| Breakup by Application | Community-Acquired Respiratory Tract Infections (CARTIs), Urinary Tract Infections (UTIs), Dental, Others |
| Breakup by Drug Origin | Natural, Semisynthetic, Synthetic |
| Breakup by Spectrum of Activity | Broad-spectrum antibiotic, Mid/Narrow-spectrum antibiotic |
| Breakup by Drug Type | Branded, Generics |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Glaxosmithkline plc, Abbott Laboratories, Allergan Plc, Hoffmann-La Roche Ltd., Pfizer Inc., Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Oral Antibiotics Market Analysis
8.1 Key Industry Highlights
8.2 Global Oral Antibiotics Historical Market (2018-2022)
8.3 Global Oral Antibiotics Market Forecast (2023-2028)
8.4 Global Oral Antibiotics Market by Class
8.4.1 Beta Lactam and Beta Lactamase Inhibitors
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.1.4 Breakup by Type
8.4.1.4.1 Penicillin
8.4.1.4.2 Cephalosporin
8.4.1.4.3 Others
8.4.2 Quinolones
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.4.3 Macrolides
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2018-2022)
8.4.3.3 Forecast Trend (2023-2028)
8.4.4 Others
8.5 Global Oral Antibiotics Market by Application
8.5.1 Community-Acquired Respiratory Tract Infections (CARTIs)
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.1.4 Breakup by Type
8.5.1.4.1 Upper Respiratory Tract Infections (URTI)
8.5.1.4.2 Lower Respiratory Tract Infections (LRTIs)
8.5.2 Urinary Tract Infections (UTIs)
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.5.3 Dental
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2018-2022)
8.5.3.3 Forecast Trend (2023-2028)
8.5.3.4 Breakup by Type
8.5.3.4.1 Combination
8.5.3.4.2 Monotherapies
8.5.4 Others
8.6 Global Oral Antibiotics Market by Drug Origin
8.6.1 Natural
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2022)
8.6.1.3 Forecast Trend (2023-2028)
8.6.2 Semisynthetic
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2022)
8.6.2.3 Forecast Trend (2023-2028)
8.6.3 Synthetic
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2018-2022)
8.6.3.3 Forecast Trend (2023-2028)
8.7 Global Oral Antibiotics Market by Spectrum of Activity
8.7.1 Broad-spectrum antibiotic
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2018-2022)
8.7.1.3 Forecast Trend (2023-2028)
8.7.2 Mid/Narrow-spectrum antibiotic
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2018-2022)
8.7.2.3 Forecast Trend (2023-2028)
8.8 Global Oral Antibiotics Market by Drug Type
8.8.1 Branded
8.8.1.1 Market Share
8.8.1.2 Historical Trend (2018-2022)
8.8.1.3 Forecast Trend (2023-2028)
8.8.2 Generics
8.8.2.1 Market Share
8.8.2.2 Historical Trend (2018-2022)
8.8.2.3 Forecast Trend (2023-2028)
8.9 Global Oral Antibiotics Market by Region
8.9.1 North America
8.9.1.1 Market Share
8.9.1.2 Historical Trend (2018-2022)
8.9.1.3 Forecast Trend (2023-2028)
8.9.2 Europe
8.9.2.1 Market Share
8.9.2.2 Historical Trend (2018-2022)
8.9.2.3 Forecast Trend (2023-2028)
8.9.3 Asia Pacific
8.9.3.1 Market Share
8.9.3.2 Historical Trend (2018-2022)
8.9.3.3 Forecast Trend (2023-2028)
8.9.4 Latin America
8.9.4.1 Market Share
8.9.4.2 Historical Trend (2018-2022)
8.9.4.3 Forecast Trend (2023-2028)
8.9.5 Middle East and Africa
8.9.5.1 Market Share
8.9.5.2 Historical Trend (2018-2022)
8.9.5.3 Forecast Trend (2023-2028)
9 North America Oral Antibiotics Market Analysis
9.1 United States of America
9.1.1 Market Share
9.1.2 Historical Trend (2018-2022)
9.1.3 Forecast Trend (2023-2028)
9.2 Canada
9.2.1 Market Share
9.2.2 Historical Trend (2018-2022)
9.2.3 Forecast Trend (2023-2028)
10 Europe Oral Antibiotics Market Analysis
10.1 United Kingdom
10.1.1 Market Share
10.1.2 Historical Trend (2018-2022)
10.1.3 Forecast Trend (2023-2028)
10.2 Germany
10.2.1 Market Share
10.2.2 Historical Trend (2018-2022)
10.2.3 Forecast Trend (2023-2028)
10.3 France
10.3.1 Market Share
10.3.2 Historical Trend (2018-2022)
10.3.3 Forecast Trend (2023-2028)
10.4 Italy
10.4.1 Market Share
10.4.2 Historical Trend (2018-2022)
10.4.3 Forecast Trend (2023-2028)
10.5 Others
11 Asia Pacific Oral Antibiotics Market Analysis
11.1 China
11.1.1 Market Share
11.1.2 Historical Trend (2018-2022)
11.1.3 Forecast Trend (2023-2028)
11.2 Japan
11.2.1 Market Share
11.2.2 Historical Trend (2018-2022)
11.2.3 Forecast Trend (2023-2028)
11.3 India
11.3.1 Market Share
11.3.2 Historical Trend (2018-2022)
11.3.3 Forecast Trend (2023-2028)
11.4 ASEAN
11.4.1 Market Share
11.4.2 Historical Trend (2018-2022)
11.4.3 Forecast Trend (2023-2028)
11.5 Australia
11.5.1 Market Share
11.5.2 Historical Trend (2018-2022)
11.5.3 Forecast Trend (2023-2028)
11.6 Others
12 Latin America Oral Antibiotics Market Analysis
12.1 Brazil
12.1.1 Market Share
12.1.2 Historical Trend (2018-2022)
12.1.3 Forecast Trend (2023-2028)
12.2 Argentina
12.2.1 Market Share
12.2.2 Historical Trend (2018-2022)
12.2.3 Forecast Trend (2023-2028)
12.3 Mexico
12.3.1 Market Share
12.3.2 Historical Trend (2018-2022)
12.3.3 Forecast Trend (2023-2028)
12.4 Others
13 Middle East and Africa Oral Antibiotics Market Analysis
13.1 Saudi Arabia
13.1.1 Market Share
13.1.2 Historical Trend (2018-2022)
13.1.3 Forecast Trend (2023-2028)
13.2 United Arab Emirates
13.2.1 Market Share
13.2.2 Historical Trend (2018-2022)
13.2.3 Forecast Trend (2023-2028)
13.3 Nigeria
13.3.1 Market Share
13.3.2 Historical Trend (2018-2022)
13.3.3 Forecast Trend (2023-2028)
13.4 South Africa
13.4.1 Market Share
13.4.2 Historical Trend (2018-2022)
13.4.3 Forecast Trend (2023-2028)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Company Profiles
16.2.1 Glaxosmithkline plc
16.2.1.1 Company Overview
16.2.1.2 Product Portfolio
16.2.1.3 Demographic Reach and Achievements
16.2.1.4 Certifications
16.2.2 Abbott Laboratories
16.2.2.1 Company Overview
16.2.2.2 Product Portfolio
16.2.2.3 Demographic Reach and Achievements
16.2.2.4 Certifications
16.2.3 Allergan Plc
16.2.3.1 Company Overview
16.2.3.2 Product Portfolio
16.2.3.3 Demographic Reach and Achievements
16.2.3.4 Certifications
16.2.4 Hoffmann-La Roche Ltd.
16.2.4.1 Company Overview
16.2.4.2 Product Portfolio
16.2.4.3 Demographic Reach and Achievements
16.2.4.4 Certifications
16.2.5 Pfizer Inc.
16.2.5.1 Company Overview
16.2.5.2 Product Portfolio
16.2.5.3 Demographic Reach and Achievements
16.2.5.4 Certifications
16.2.6 Others
17 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Oral Antibiotics Market: Key Industry Highlights, 2018 and 2028
2. Global Oral Antibiotics Historical Market: Breakup by Class (USD Million), 2018-2022
3. Global Oral Antibiotics Market Forecast: Breakup by Class (USD Million), 2023-2028
4. Global Oral Antibiotics Historical Market: Breakup by Application (USD Million), 2018-2022
5. Global Oral Antibiotics Market Forecast: Breakup by Application (USD Million), 2023-2028
6. Global Oral Antibiotics Historical Market: Breakup by Drug Origin (USD Million), 2018-2022
7. Global Oral Antibiotics Market Forecast: Breakup by Drug Origin (USD Million), 2023-2028
8. Global Oral Antibiotics Historical Market: Breakup by Spectrum of Activity (USD Million), 2018-2022
9. Global Oral Antibiotics Market Forecast: Breakup by Spectrum of Activity (USD Million), 2023-2028
10. Global Oral Antibiotics Historical Market: Breakup by Drug Type (USD Million), 2018-2022
11. Global Oral Antibiotics Market Forecast: Breakup by Drug Type (USD Million), 2023-2028
12. Global Oral Antibiotics Historical Market: Breakup by Region (USD Million), 2018-2022
13. Global Oral Antibiotics Market Forecast: Breakup by Region (USD Million), 2023-2028
14. North America Oral Antibiotics Historical Market: Breakup by Country (USD Million), 2018-2022
15. North America Oral Antibiotics Market Forecast: Breakup by Country (USD Million), 2023-2028
16. Europe Oral Antibiotics Historical Market: Breakup by Country (USD Million), 2018-2022
17. Europe Oral Antibiotics Market Forecast: Breakup by Country (USD Million), 2023-2028
18. Asia Pacific Oral Antibiotics Historical Market: Breakup by Country (USD Million), 2018-2022
19. Asia Pacific Oral Antibiotics Market Forecast: Breakup by Country (USD Million), 2023-2028
20. Latin America Oral Antibiotics Historical Market: Breakup by Country (USD Million), 2018-2022
21. Latin America Oral Antibiotics Market Forecast: Breakup by Country (USD Million), 2023-2028
22. Middle East and Africa Oral Antibiotics Historical Market: Breakup by Country (USD Million), 2018-2022
23. Middle East and Africa Oral Antibiotics Market Forecast: Breakup by Country (USD Million), 2023-2028
24. Global Oral Antibiotics Market Structure
Key Questions Answered in the Report
In 2021, the global oral antibiotics market attained a value of over USD 18,365.8 million.
The market is projected to grow at a CAGR of 2.7% between 2023 and 2028.
The market is estimated to witness a healthy growth in the forecast period of 2023-2028 to reach more than USD 23,306.1 million by 2027.
The market is being propelled by the extensive use of oral antibiotics for the treatment of infectious diseases, the increasing approvals of oral antibiotics by governments, and the growing prevalence of urinary tract infections (UTIs).
The industry is estimated to be fuelled by the growing focus on global health threats, the rising attempts to develop new antibiotics, and the increasing investment in research and development (R&D) activities of oral antibiotics.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The major classes of oral antibiotics in the industry are beta lactam and beta lactamase inhibitors, quinolones, and macrolides, among others.
The significant applications in the market are community-acquired respiratory tract infections (CARTIs), urinary tract infections (UTIs), and dental, among others.
The different drug origins of oral antibiotics are natural, semisynthetic, and synthetic.
The various spectrum of activities of oral antibiotics are broad-spectrum antibiotic and mid/narrow-spectrum antibiotic.
The major drug types of oral antibiotics are branded and generics.
The major players in the industry are Glaxosmithkline plc, Abbott Laboratories, Allergan Plc, Hoffmann-La Roche Ltd., and Pfizer Inc., among others.
Analyst Review
The global oral antibiotics market attained a value of over USD 18,365.8 million in 2021, driven by the extensive use of oral antibiotics for the treatment of infectious diseases. Aided by the growing focus on global health threats, the market is expected to witness a further growth in the forecast period of 2023-2028, growing at a CAGR of 2.7%. The market is projected to reach more than USD 23,306.1 million by 2027.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its classes, the oral antibiotics industry can be segmented into beta lactam and beta lactamase inhibitors, quinolones, and macrolides, among others. By applications, the market is categorised into community-acquired respiratory tract infections (CARTIs), urinary tract infections (UTIs), and dental, among others. On the basis of drug origins, the industry is divided into natural, semisynthetic, and synthetic. Based on spectrum of activities, the market is classified into broad-spectrum antibiotic and mid/narrow-spectrum antibiotic. By drug types, the market is bifurcated into branded and generics. The major regional markets for oral antibiotics are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Glaxosmithkline plc, Abbott Laboratories, Allergan Plc, Hoffmann-La Roche Ltd., and Pfizer Inc., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2799-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$3999-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
NEWSLETTER